Renaissance Technologies (RenTech)'s TARS Position Overview
Renaissance Technologies (RenTech) (via Renaissance Technologies LLC (Rentech)) currently holds 64,100 shares of Tarsus Pharmaceuticals, Inc. (TARS) worth $5.25 M, representing 0.01% of the portfolio. First purchased in 2022-Q2, this medium-term investment has been held for 9 quarters.
Based on 13F filings, Renaissance Technologies (RenTech) has maintained a strategic position in TARS, demonstrating sustained confidence in this investment. Largest addition occurred in Q3 2025, adding 41,600 shares. Largest reduction occurred in Q4 2023, reducing 106,900 shares.
Analysis based on 13F filings available since 2013 Q2
Renaissance Technologies (RenTech)'s Tarsus Pharmaceuticals (TARS) Holding Value Over Time
Track share changes against reported price movement
Quarterly Tarsus Pharmaceuticals (TARS) Trades by Renaissance Technologies (RenTech)
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | +22,500 | Add 54.09% | 64,100 | $81.88 |
| Q3 2025 | +41,600 | New Buy | 41,600 | $59.43 |
| Q4 2023 | -106,900 | Sold Out | 0 | $0.00 |
| Q3 2023 | -7,600 | Reduce 6.64% | 106,900 | $17.77 |
| Q2 2023 | +40,500 | Add 54.73% | 114,500 | $0.02 |
| Q1 2023 | +8,400 | Add 12.80% | 74,000 | $0.01 |
| Q4 2022 | -3,900 | Reduce 5.61% | 65,600 | $0.01 |
| Q3 2022 | +9,200 | Add 15.26% | 69,500 | $17.12 |
| Q2 2022 | +60,300 | New Buy | 60,300 | $14.59 |
Renaissance Technologies (RenTech)'s Tarsus Pharmaceuticals Investment FAQs
Renaissance Technologies (RenTech) first purchased Tarsus Pharmaceuticals, Inc. (TARS) in Q2 2022, acquiring 60,300 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Renaissance Technologies (RenTech) has held Tarsus Pharmaceuticals, Inc. (TARS) for 9 quarters since Q2 2022.
Renaissance Technologies (RenTech)'s largest addition to Tarsus Pharmaceuticals, Inc. (TARS) was in Q2 2022, adding 60,300 shares worth $880,000.
According to the latest 13F filing for Q4 2025, Renaissance Technologies (RenTech)'s firm, Renaissance Technologies LLC (Rentech), owns 64,100 shares of Tarsus Pharmaceuticals, Inc. (TARS), valued at approximately $5.25 M.
As of the Q4 2025 filing, Tarsus Pharmaceuticals, Inc. (TARS) represents approximately 0.01% of Renaissance Technologies (RenTech)'s publicly disclosed stock portfolio, making it one of their key holdings.
Renaissance Technologies (RenTech)'s peak holding in Tarsus Pharmaceuticals, Inc. (TARS) was 114,500 shares, as reported at the end of Q2 2023.